Fig. 5.

Cpn60.2-mortalin interaction contributes to the anti-apoptotic potential of Cpn60.2. Macrophages were transfected with Cpn60.2 or BSA (control) then left untreated or stimulated with staurosporine (STP). Where indicated, cells were pre-treated with 100 nM MKT-077 30 min prior to protein transfection. Cells were then subjected to PARP degradation assay as in Fig. 3B. Data are representative of three independent experiments.